# Beijing Syngentech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-syngentech-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.syngentech.com.cn
- Latest round: Series A (Nov 19, 2018)
- Investors on record: 3

## About

Based in Beijing, China and established in 2014, Beijing Syngentech Co., LTD operates as a healthcare company that focuses on gene therapy and bio-pharmaceuticals research.

The company’s main business revolves around providing cutting-edge synthetic biology services and products, including high-throughput gene function screening, drug resistance screening services, and CRISPR-Cas9 vector design. Its products are used in the fields of medical research, pharmaceutical development, and personalized healthcare solutions.

The company generates revenue by providing its comprehensive suite of synthetic biology services and products to a diverse clientele in the scientific and healthcare sectors.

## Funding rounds

- Series A, Nov 19, 2018 — Junyue Capital
- Series A, Dec 5, 2017 — Lotus Lake Capital, Beijing Gozap Technology Co., Ltd.

## Investors

- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A
- Beijing Gozap Technology Co., Ltd. — Series A
- Junyue Capital (https://capitalatlas.ai/funds/junyue-capital) — Series A